国产情侣

Skip to main content
Download PDF
  • Study Protocol
  • Published:

A cluster randomized controlled trial to assess the impact of the 鈥楥aring for Providers to Improve Patient Experience鈥� (CPIPE) intervention in Kenya and Ghana: study protocol

国产情侣 Public Health volume听24, Article听number:听2509 (2024) Cite this article

Abstract

Background

Poor person-centered maternal care (PCMC) contributes to high maternal mortality and morbidity, directly and indirectly, through lack of, delayed, inadequate, unnecessary, or harmful care. While evidence on poor PCMC prevalence, as well as inequities, expanded in the last decade, there is still a significant gap in evidence-based interventions to address PCMC. We describe the protocol for a trial to test the effectiveness of the 鈥淐aring for Providers to Improve Patient Experience鈥� (CPIPE) intervention, which includes five strategies, targeting provider stress and bias as intermediate factors to improve PCMC and address inequities.

Methods

The trial will assess the effect of CPIPE on PCMC, as well as on intermediate and distal outcomes, using a two-arm cluster randomized controlled trial in 40 health facilities in Migori and Homa Bay Counties in Kenya and Upper East and Northeast Regions in Ghana. Twenty facilities in each country will be randomized to 10 intervention and 10 control sites. The primary intervention targets are all healthcare workers who provide maternal health services. The intervention impact will be assessed among healthcare workers in the study health facilities and among women who give birth in the study health facilities. The primary outcome is PCMC measured with the PCMC scale, via multiple cross-sectional surveys of mothers who gave birth in the preceding 12 weeks in study facilities at baseline (prior to the intervention), midline (6 months after intervention start), and endline (12 months post-baseline) (N鈥�=鈥�2000 across both countries at each time point). Additionally, 400 providers in the study facilities across both countries will be followed longitudinally at baseline, midline, and endline, to assess intermediate outcomes. The trial incorporates a mixed-methods design; survey data alongside in-depth interviews (IDIs) with healthcare facility leaders, providers, and mothers to qualitatively explore factors influencing the outcomes. Finally, we will collect process and cost data to assess intervention fidelity and cost-effectiveness.

Discussion

This trial will be the first to rigorously assess an intervention to improve PCMC that addresses both provider stress and bias and will advance the evidence base for interventions to improve PCMC and contribute to equity in maternal and neonatal health.

Trial registration

ClinicalTrials.gov: NCT06085105. Protocol version and date: v2-11-07-23

Peer Review reports

Background

Maternal mortality and morbidity remain very high in sub-Saharan Africa (SSA), despite progress in the last decade [1]. The estimated maternal mortality ratio for SSA is 546 per 100,000 live births鈥攚ith Ghana and Kenya at 308 and 510, respectively, compared to about 12 in high-income regions [1]. Further, for every woman who dies, about 20 others suffer from various morbidities [2]. These outcomes occur alongside poor fetal outcomes including stillbirths, prematurity, and early neonatal deaths. High quality care during childbirth is critical for preventing maternal and neonatal mortality, given roughly three-quarters of maternal and fetal deaths occur from complications during labor, delivery, and the first 24 h postpartum [3]. While complications are difficult to predict, they can effectively be managed, and deaths averted when recognized and treated promptly [3, 4]. Thus, skilled care by health professionals who can identify and treat complications and provide basic care and referrals, are essential at every delivery [3].

Until recently, most efforts to improve maternal and child health (MCH) outcomes in SSA focused on increasing the use of MCH services. While countries in SSA, such as Ghana and Kenya, report increasing coverage for facility births, significant gaps in equity and quality of care persist between and within countries [5]. For instance, although about 70% of births in SSA occur in health facilities, wide disparities in facility-based births persist, especially by SES [6]. Further, poor quality care in many health facilities, coupled with the lack of reduction in mortality on par with increased facility deliveries, has called attention to the quality of care [7,8,9]. Quality of care includes both service provision and experience of care [10]. Most efforts have, however, emphasized service provision鈥攖he technical aspects of quality of care; fewer address experience of care鈥攖he person-centered dimensions and vehicle by which care is delivered [11].

Person-centered maternity care (PCMC) is a key component of quality of care that captures the interpersonal aspects of care and impacts patient experience. It emphasizes maternal healthcare that is respectful, compassionate, and responsive to individual patient preferences, needs, and values [12]. Key domains of PCMC include dignity and respect, communication and autonomy, and supportive care. PCMC is a critical component of a human rights framework, as everyone has a right to be treated with dignity and respect, including during pregnancy and childbirth [13,14,15,16]. However, globally, studies have shown significant gaps in PCMC as evidenced by disrespect and abuse, poor communication, lack of respect for women鈥檚 autonomy, and lack of supportive care during prenatal care and childbirth [17,18,19,20]. Such poor PCMC contributes to both the low rates of facility-based deliveries and the disparities [21, 22], with the poorest outcomes among the most vulnerable, who are more likely to be mistreated and stigmatized in health facilities [18, 19, 23, 24]. Further, PCMC contributes to improved health outcomes through timeliness, patient engagement, safety, improved psychosocial health, and patient and provider satisfaction [25, 26]. Recent research also shows PCMC domains are associated with improved maternal and neonatal outcomes such as shorter duration of labor, decreased cesarean and instrumental vaginal birth, higher five-minute Apgar scores, early postnatal care, breastfeeding, and lower risk of screening positive for post-partum depression [27,28,29,30,31,32]. Poor PCMC, therefore, undermines health gains for mothers and babies [33].

Several studies have highlighted the multilevel drivers of poor PCMC, which include inadequate provider knowledge of PCMC, poor provider attitudes, provider stress, burnout, and bias, power asymmetry between patients and providers, lack of accountability mechanisms, institutional and health system factors, and broader social and gender norms that facilitate and normalize disrespect and abuse [34,35,36,37,38,39,40,41]. There is, however, still limited research on interventions to improve PCMC in LMICs, with most interventions focused on individual drivers such as provider knowledge [42, 43]. Further, existing interventions in LMICs do not address the role of provider stress, burnout, and difficult patient-provider interactions in PCMC, nor do they explicitly address the inequities in PCMC [38, 44,45,46]. To address the gap in evidence-based interventions to improve PCMC, we designed the 鈥淐aring for Providers to Improve Patient Experience鈥� (CPIPE) intervention to address drivers of poor PCMC and center the unique needs of vulnerable women in LMICs. The development of the intervention has been previously described in detail [47].

CPIPE is a theory and evidence-based intervention that was designed through an iterative process of formative research and feedback from stakeholders, and informed by the Ecological Perspective [48], Social Cognitive Theory [49], and Trauma Informed System framework [50]. It leverages 5 strategies: provider simulation-enhanced training, peer support, mentorship, embedded champions, and leadership engagement (Fig. 1). The training, which is delivered through short didactic, interactive training, and reflective sessions over 2 days, includes content on PCMC, stress management, dealing with difficult situations, and implicit and explicit bias. This content is integrated into customized highly realistic emergency obstetric and neonatal care (EmONC) simulations and teamwork and communication activities designed in collaboration with to enable providers to apply concepts in the context of an emergency scenario with guided self-reflection through debriefing [51]. The two-day training is followed by monthly refreshers for six months, as well as resources shared on WhatsApp to reinforce training content over 6 months. Peer support groups are cadre-specific groups of the providers that are facilitated monthly by a peer leader to debrief on events at the maternity unit, brainstorm solutions, and engage in stress management activities. Mentorship involves intentional mentor-mentee pairing based on a survey of mentor and mentee needs and preferences to facilitate the transfer of knowledge and skills through one-on-one relationships. Embedded champions are selected by their peers in each facility to lead intervention activities in their facility, including facilitating the monthly refreshers and peer support groups. As part of our leadership engagement, a Community Advisory Board (CAB), with representatives from the county/regional, facility, as well as providers and patients, guides the implementation and serves as a body for high-level advocacy. The 2-day training aims to increase provider knowledge, skills, and self-efficacy to impact attitudes and behaviors towards preventing burnout, mitigating bias, and improving PCMC while the additional strategies create an enabling environment for behavior change.

Fig. 1
figure 1

CPIPE Intervention strategies

Full size image

A pilot study in Kenya showed the CPIPE intervention has high feasibility, acceptability, and preliminary effectiveness on provider stress, burnout, bias, and provider-reported PCMC provision [20, 52]. Thus, the next step is to assess the effectiveness of CPIPE on patient-reported measures and to explore 颁笔滨笔贰鈥檚 mechanisms of action in a rigorously designed and fully powered study. This paper describes the protocol for this next phase of our work.

Methods

Aims

Our specific aims, as shown in Fig. 2, are to:

Fig. 2
figure 2

CPIPE conceptual framework

Full size image

Assess the effectiveness of the CPIPE intervention on PCMC

We hypothesize that CPIPE will improve PCMC for all women, but especially for low SES women. In addition, we will conduct a cost-effectiveness analysis of CPIPE on PCMC.

Examine the mechanisms of impact of CPIPE

We hypothesize that CPIPE will improve intermediate outcomes (provider knowledge and self-efficacy, stress, burnout, and bias levels), which will, in turn, impact PCMC. We will assess the effect of the intervention on these intermediate outcomes and examine if changes in these outcomes account for the effect of CPIPE on PCMC. We will also assess implementation outcomes, including fidelity and quality of implementation, that may contribute to differential effects.

Assess the impact of the CPIPE intervention on distal outcomes

This is an exploratory aim in which we will examine if the intervention impacts more distal outcomes in our conceptual framework, including timely postnatal care, breastfeeding initiation and exclusivity, postpartum mental well-being, neonatal complications, and maternal and neonatal mortality, and if changes in PCMC account for these effects.

Study design and setting

We plan to test the effectiveness of the CPIPE intervention on PCMC and intermediate and distal outcomes using a two-arm cluster randomized controlled trial (RCT) in 40 high volume health facilities in Migori and Homa Bay Counties in western Kenya and in the Upper East and Northeast Regions of northern Ghana. The counties and regions in each country were selected for having among the worst maternal and neonatal health outcomes, having similar characteristics, and based on our existing institutional relationships. Migori and Homabay are neighboring, and similar counties located along Lake Victoria in in western Kenya that have comparable maternal and neonatal mortality burden. They have 8 sub-counties, each with a sub-county hospital and one county referral hospital. There are about 155 and 263 health facilities in Migori and Homa Bay, respectively, including county and sub-county hospitals, health centers, faith-based, and private health facilities [53]. The Upper East and North East Regions are also neighboring regions located in the north-eastern corner of Ghana, both sharing borders with Togo to the east that also have similar characteristics and maternal and neonatal mortality burden. The Upper East Region shares boundaries with Burkina Faso to the north and Northeast Region to the south. The Upper East region is divided into 15 districts, with 11 district hospital, 67 health centers, 419 CHPS compounds and one regional hospital that serves as a referral center for the district hospitals [54, 55]. Northeast is divided into six districts, with five district hospitals, 21 health centers, and 154 CHPS compounds [56].

Randomization

Randomizing individual providers is not ideal because of a high potential for contamination within facilities and goal of changing facility culture. A cluster RCT design allows us to address threats to internal validity and account for natural clustering of providers within facilities [57]. Forty facilities will be randomized to intervention (N鈥�=鈥�20) and control (N鈥�=鈥�20), with arms stratified by country(10 intervention and 10 control facilities in each country). To reduce the risk of contamination due to interaction of providers within the same sub-counties and districts, randomization will be at the sub-county/district level such that control and intervention facilities are not in the same sub-county/district. The facility randomization will be done by a statistician not directly involved in the study. The intervention group will receive all strategies of the CPIPE intervention strategies over a period of 6 months after the baseline data collection. At the end of the 6-month implementation, we will collect midline data. Facilities will then be encouraged to continue with the intervention activities without involvement of the study for an additional 6 months, with final data collection at 12 months (endline). The control group will not receive the CPIPE intervention during the 12-month data collection period but will maintain their usual facility level activities. We plan to implement the intervention in the control sites after the endline data collection (assuming preliminary effectiveness). The protocol complies with the standard protocol items for cluster randomized trials. The study design, outcomes, and participant flow are summarized in Figs. 2 and 3.

Fig. 3
figure 3

CPIPE study design

Full size image

Study population

The study population includes providers and women who give birth in the study facilities. Providers are the recipients of the intervention as well as potential beneficiaries. All healthcare workers (including nurses, midwifes, doctors, clinical/medical officers, and support staff) who provide MCH services (including antenatal, intrapartum, and postnatal care) in study facilities will be eligible for the intervention. Including all providers in a facility will facilitate an enabling facility culture, across all cadres. Women who receive care in the study facilities are the anticipated beneficiaries of the intervention; we will obtain data on the primary outcomes among women. Study participants will be women who gave birth in the facility in the 12 weeks preceding data collection. Other eligibility criteria are shown in Table 1.

Table 1 Eligibility criteria
Full size table

Study procedures

Intervention

This will include participation in an initial 2-day training, followed by monthly refreshers to reinforce training content; peer support groups, each comprising 5鈥�10 providers of similar cadre, who will meet for about 1鈥�2 h every month; and in a mentorship program, in which mentor/mentee pairs are encouraged to meet once a month but will be primarily mentee-driven. Each facility will have two embedded champions, providers nominated by their peers who will lead activities at each site including facilitating refreshers and peer support groups. Leadership engagement will occur throughout the project through continuous interaction with leaders in the study sites and with a community advisory board which will meet quarterly to provide input on implementation and respond to provider concerns to address sources of stress.

Data collection

We will collect data at 3 time points in the intervention and control sites: baseline (T1) prior to the intervention start at each facility, midline 6 months post-baseline/intervention start (T2) to assess immediate impact, and endline 12 months after baseline (6 months post-intervention) (T3) to assess sustainability. Survey data will be collected utilizing Redcap programmed tablets. Process data will be collected throughout the study to assess intervention fidelity and implementation using study logs and Redcap. The provider cohort will be followed longitudinally for 12 months following baseline enrollment. The women鈥檚 sample will be multiple cross-sections, where data will be collected from 3 different groups of women at the 3 time points. We will use a mixed-methods approach. Quantitative data will be obtained from surveys followed by IDIs to qualitatively explore factors that may influence outcomes. We will also assess intervention fidelity through observations of intervention activities and a review of project logs [58, 59].

Sample size

Participants include 400 providers (N鈥�=鈥�400) followed longitudinally and N鈥�=鈥�6000 women participating in multiple cross-sectional surveys- baseline (N鈥�=鈥�2000), midline (N鈥�=鈥�2000), and endline (N鈥�=鈥�2000)- across both countries: i.e., 200 providers followed longitudinally, and 3000 women interviewed once across three time points (N鈥�=鈥�1000 at each time-point) from both intervention and control facilities, in each country. We will then conduct IDIs with a subset of providers (N鈥�=鈥�鈭�鈥�40), facility leaders (N鈥�=鈥�鈭�鈥�40), and mothers (N鈥�=鈥�鈭�鈥�40) to explore pathways to intervention outcomes. Power analysis for sample size justification is described in the analysis section.

Recruitment

The study will first be introduced to the county/region, sub-county/district, and facility leadership, who will inform all providers who work in MCH units in the study facilities. The study鈥檚 field team will then approach individual providers to provide additional information and obtain written informed consent. Only providers who provide individual informed consent will be enrolled. They will be made aware that participation in the study is voluntary and will not affect their positions in any way. Providers in the selected facilities will be recruited by the field team and consented at the beginning of the study and then followed longitudinally for the three rounds of data collection. Women will be recruited at health facilities following discharge from the facilities and after postnatal care and in the immediate communities served by the study facilities. They will first be identified with the help of healthcare providers, community health volunteers, and a review of facility birth registers at the study sites. The study team will then screen them for eligibility, provide information about the study, and obtain individual informed consent if interested. Only women who provide written consent will be interviewed either at the facility, at their homes, or at a preferred location. Following surveys, all participants will be asked if they are willing to be contacted for follow-up IDIs; a subset of those who consent will be re-contacted for the IDIs. Participants for IDIs will be purposively sampled balancing for age, time/weeks since birth, and post-natal care attendance, to represent the range of experiences. All women will be consented prior to IDIs.

Retention

Because providers will be followed longitudinally several steps have been planned to reduce attrition. First, providers who plan to leave the study within the study period will not be enrolled at baseline. Second, we will discuss with facility and health system leaders in the study sites to reduce rotation and transfer of providers during the study period unless necessary. Third providers will receive an incentive for participation in all implementation and research activities. Attrition is not a concern for women since they will not be followed longitudinally.

Study outcomes

Aim 1: The primary outcome of the study is PCMC to assess the effectiveness of the CPIPE intervention on PCMC.

PCMC will be measured with the PCMC scale developed and validated by our team in Kenya and Ghana [60,61,62]. The PCMC scale is a 30-item scale administered to perinatal women with 3 sub-scales for dignity and respect, communication and autonomy, and supportive care. Items for each scale are summed to create a score, which is standardized to range from 0 to 100, where higher scores indicate more person-centered care.

Aim 2: Secondary outcomes to examine the mechanisms of impact of CPIPE on PCMC include

provider stress and burnout, bias awareness and mitigation, as well as provider knowledge, self-efficacy, and behaviors. Provider stress and burnout will be measured using the Cohen perceived stress scale [63] and the Shirom-Melamed Burnout measure [64], which we successfully used in Ghana and Kenya with demonstrated good psychometric properties [46, 65]. For implicit and explicit bias, we will use the Bias Awareness and Mitigation in Maternal Health scale [66] and vignettes, developed and tested in our prior research [67]. We will measure provider knowledge, self-efficacy, and behaviors related to stress, bias, and PCMC, using tools developed for the evaluation of the pilot study. Longitudinal provider surveys will be used to collect this data in all study arms at baseline, midline, and endline.

Aim 3: Outcomes to Assess the effect of the CPIPE intervention on distal outcomes in our conceptual framework (Fig. 2) include

receipt of timely postnatal care, breastfeeding initiation and exclusivity, postpartum mental well-being, and post-delivery neonatal complications, which we have shown are associated with PCMC [29, 30]. These will be measured using questions on the timing of breastfeeding onset and current breastfeeding practices, the Edinburgh postnatal depression scale [68], and other questions on postpartum and newborn health in the women鈥檚 survey. We will also collect facility-level data on coverage indicators and maternal and neonatal morbidity and mortality from facility records. All study outcomes and sample measures are shown in Table 2. As part of all surveys, we will collect data on various covariates shown in Table 2.

Table 2 Study outcomes, measures, sources, and timing of capture
Full size table

Analysis plan

Data quality assurance, initial analyses, and missing data

We will use Redcap to perform real-time checks for data quality assurance [69, 70]. We will use frequency tables and measures of central tendency and variability for continuous variables to characterize the sample overall and by randomization group. If the two groups differ significantly at baseline on one or more covariates, we will use methods based on the Rubin causal model (e.g., propensity scores, double-robust estimation) to obtain the desired effect estimates under the counterfactual assumption of balanced groups [71, 72]. We will address incomplete data with direct maximum likelihood (ML) and multiple imputation (MI) [73] because they make the relatively mild assumption that incomplete data arise from a conditionally missing-at-random (MAR) mechanism [74]. Auxiliary variables will be included to help meet the MAR assumption [75]. The proposed analyses will be conducted using STATA. All program code and results will be documented extensively and archived to enable future review, transparency, and results reproducibility.

Aim 1

We hypothesize that mothers in the CPIPE intervention group will have higher mean PCMC scores than mothers in the control group at 6 months (H1a) and 12 months (H1b) after baseline. To test hypotheses H1a-H1b, in primary analyses we will fit two-level linear mixed models (LMM) to the PCMC score. Each of these two models will include a fixed effect for the study arm with random intercepts for facility ID to account for the clustering of women within health facilities. Because we will compare CPIPE to control at 6 months and then repeat the same comparison at 12 months, alpha (伪) will be set at 0.05/2鈥�=鈥�0.025 for each of these two planned comparisons. In secondary analyses for Aim 1, we will extend the LMMs for PCMC to include effects for age and SES and their interactions with the intervention group indicator to explore whether the CPIPE intervention differentially benefits younger and lower SES women. Sex as a Biological Variable is not applicable: all participants will be biological females.

Aim 1 Power Analysis:

We used the NCSS PASS [76] module for a two-level multilevel model with a continuous outcome and randomization at the cluster (i.e., health facility) level to compute the minimum detectable effect size estimates for hypotheses H1a-H1b. We assumed power of 0.80, 伪鈥�=鈥�0.025 per comparison, and N鈥�=鈥�2000 women from 40 facilities. We further assumed ICC鈥�=鈥�0.16 based on our previous data [20, 77]. The minimum detectable standardized mean difference was d鈥�=鈥�0.41, which is between small and medium effect size, suggesting the proposed primary analyses have sufficient power to detect small to medium effects [78].

Aim 2

We anticipate that the intervention will positively impact the intermediate outcomes in our conceptual model (Fig. 1), leading to an improvement in PCMC. We thus hypothesize that, following CPIPE exposure, intervention providers will have, higher mean scores on provider knowledge (H2a); self-efficacy (H2b); enabling environment (H2c); behavior (H2d), and lower mean scores on work-related psychological effects (stress, burnout, and bias) (H2e) relative to control providers. To test these hypotheses, we will fit three-level LMMs to each intermediate outcome, with fixed effects for study arm, time, and their interaction, random intercepts for facility ID to account for clustering of providers within health facilities, and random intercepts, random slopes, and their covariance for person ID to account for clustering of repeated measurements within providers. We will perform time-averaged comparisons of repeatedly measured post-baseline observations of the key intermediate outcomes across study arms to examine CPIPE intervention effects.

In secondary exploratory analyses, we will investigate whether the intermediate outcomes measured for providers at 6 months mediate the relationship between CPIPE intervention assignment and PCMC at 12 months. These analyses will be conducted using principles of structural equation modeling (SEM) and causal mediation methods [1]. We will explore whether sex as a biological variable differentially affects intervention effects on the provider-level primary analyses by adding a sex main effect and a sex-by-CPIPE assignment interaction term to the LMM models. Sex as a biological variable is not applicable to the mediation analyses due to the outcome applying to women only.

Aim 2 Power Analysis

We used the NCSS PASS [76] module for three-level multilevel models with randomization at the cluster level to compute the minimum detectable effect size estimates for hypotheses H2a-H2e. We assumed power鈥�=鈥�0.80, 伪鈥�=鈥�0.05, and 2 post-baseline repeated assessments from N鈥�=鈥�400 enrolled providers from 40 health facilities (N鈥�=鈥�320 following 20% conservatively assumed attrition based on pilot data and our planned approach to reduce attrition) [52]. We conservatively assumed ICC鈥�=鈥�0.15 based on our preliminary data [46, 67, 77]. Since the within-provider correlations are unknown, we varied them from r鈥�=鈥�.20 (small) to r鈥�=鈥�.80 (large). We computed the minimum detectable standardized mean difference d using the same inputs as listed above, yielding d鈥�=鈥�0.40 to 0.44, which are between thresholds for small (0.20) and medium (0.50) standardized effects, suggesting the sufficient power to detect small to medium effects [78].

Aim 3

Improvements in PCMC are hypothesized to impact timely and appropriate care provision, care engagement, future health-seeking, and the physical and psychosocial health of women and their babies who receive care from those facilities, all of which positively influence maternal and neonatal outcomes. Recognizing that these distal outcomes are influenced by broader contextual factors and take longer to change, we propose an exploratory third aim to assess the impact of CPIPE on these outcomes during the study period and whether they are mediated by changes in PCMC. Given the exploratory nature of this aim, initial analyses will be descriptive, with frequency tables for all distal outcomes and measures of central tendency and variability for continuous distal variables at 6 and 12 months for intervention and control sites.

While facility data will be limited to N鈥�=鈥�40 clinics, inferential analyses will be performed with N鈥�=鈥�2000 women on distal outcomes. We focus on the key outcome of receipt of timely post-natal care. We hypothesize that among mothers giving birth in the study facilities, mothers who received care in the CPIPE intervention group will be more likely to receive postnatal care within 48 h than mothers in the control group at 6 months (H3a) and 12 months (H3b) after baseline. To test H3a and H3b, we will fit two-level generalized linear mixed models (GLMM) to the binary timely postnatal care variable collected at 6 months and at 12 months. Each model will include a fixed effect for study arm and random intercepts for facilities for clustering of women within health facilities. Because we will compare CPIPE to control at 6 months and at 12 months, 伪 will be set at.05/2鈥�=鈥�0.025 for each comparison. We will use the same GLMM approach to test the effects of CPIPE on other distal outcomes. Additional secondary exploratory analyses for Aim 3 will explore whether the PCMC scores mediate the relationship between CPIPE intervention exposure and receipt of timely post-natal care. As in specific Aim 2, we will perform mediation analyses using SEM and causal mediation methods [79]. Sex as a Biological Variable is not applicable because all care recipients will be biological females.

Aim 3 Power Analysis

We used a similar approach as for Aim1 to compute the minimum detectable effect size estimates for hypotheses H3a-H3b, assuming a broad range of 24鈥�81% of women receiving timely post-natal care and ICC鈥�=鈥�0.039 at the facility level based on our previous data [20, 77]. Minimum detectable raw proportion differences were 8.3鈥�10.7%, which correspond to small to medium effects [78].

Qualitative analysis

The sample size for the qualitative study is informed by guidelines to achieve data saturation [80, 81] and a desire to purposively sample from all the study facilities. We will record interviews and transcribe audio recordings into English, translating if interviews are conducted in local languages. Transcripts will be coded and analyzed in Dedoose software utilizing collaboratively developed coding frameworks and group approaches qualitative analyses, guided by the thematic analysis approach described by Braun and Clark [82]. To capitalize on the mixed-methods design, findings from the qualitative and quantitative data collection and analyses will be integrated at the interpretation and discussion stages. All team members who collect the data will be included in the analyses to strengthen the validity of the findings.

Cost-effectiveness analysis

We will also assess the cost-effectiveness of CPIPE on PCMC.

Costing

We will use standard micro-costing techniques and include a full costing approach, which requires the estimation of both recurrent and capital costs related to the intervention. The recurrent costs will include the cost of materials used within a year, which will include the cost of personnel salaries/allowances, medical consumables, training and meetings, travels, office supplies, and overhead/administrative costs related to the intervention development and delivery. The capital costs will be the inputs or resources that usually last for more than one year, which include items such as facility/office space, equipment, and vehicles/motorbike/bicycle costs. Research costs will be excluded. Capital costs will be annualized using a discount rate of 3% and the useful life of the capital items. The total economic costs of the intervention will be estimated and then categorized into pre-intervention deployment costs, intervention implementation costs, and indirect costs.

Effectiveness

The effectiveness outcome will be the PCMC scores measured for women at 6 months and at 12 months.

Cost-effectiveness analysis

The incremental cost-effectiveness ratio (ICER) will be used in the estimation of the cost-effectiveness of the CPIPE intervention. The ICER is the incremental cost per incremental benefit due to in CPIPE intervention. A budget impact analysis will be carried out to determine the impact of the intervention implementation and scale-up on the government budget.

Process evaluation

We will conduct a process evaluation to assess implementation and intervention fidelity including adherence, exposure, quality of delivery, competence, participant responsiveness, and program differentiation [58, 59]. We will use mixed-methods approaches for this purpose, guided by Proctor鈥檚 framework [83, 84]. A fidelity monitoring tool with structured and open-ended questions will be used to document all implementation activities, noting details such as the timing of activities, participants, facilitators, the content of the activity, and what went well and what did not go well. We will also document ongoing activities at each site to identify activities that might affect the outcomes of the trial.

Timeline

The CPIPE trial will be completed over a 5-year period. We will use the first 6 months for study preparation activities, including finalizing the protocol and data collection tools, updating the curriculum with lessons learned from the pilot, and obtaining ethical and other regulatory approvals at UCSF and all sites. We will implement the intervention in 2 blocks in each country, with 10 facilities (5 intervention and 5 control) in each block. Baseline data collection for the first block will start in Y1Q3, followed by intervention implementation, midline, and endline over a period of about one and a half years. Baseline and intervention activities in the next block will start in about Y2 following the same approach in the next year. In year 3 we will offer the intervention to the control groups. Data collection across all sites is anticipated to be completed in Y4. Data cleaning, quality assessment, and preliminary analysis will occur as data are being collected. In year 5, we will continue with data analysis and preparation of manuscripts and presentations, with dissemination in Ghana, Kenya and globally.

Safety monitoring

The study has been approved by the study teams鈥� institutional review boards (IRBs) in the United States, Ghana, and Kenya (see details in ethics approval and consent to participate section). Any protocol amendments will be reported to all the relevant IRBs. The studies鈥� sponsors and IRBs agree that the activities in this protocol represent minimal risk. Thus, a data monitoring committee is not required. The study team will, however, monitor activities and data per our approved data safety monitoring plan. The research team will be trained to recognize and immediately report any adverse events to ensure the safety of participants. The PI, in consultation with the research team, will be responsible for evaluating any adverse events and responding appropriately. Participant confidentiality will be protected during data collection by conducting interviews in private locations. Participants will be assigned a unique identifier, and all data entered in the study database will only utilize this identifier. All study data will be stored in secured and encrypted servers, which only authorized study personnel can access using password-protected devices. Given the study has minimal risk, no interim analysis is planned to inform study termination, and no formal auditing is planned beyond ongoing process evaluation activities.

Discussion

The proposed intervention will be among the first, if not the first, rigorously designed and evaluated interventions to improve PCMC that address key drivers of poor PCMC, including provider stress and bias. The results will significantly advance the evidence base for interventions to improve PCMC and contribute to equity in maternal and neonatal health. A limitation of the CPIPE intervention is the inability to address structural factors such as shortage of health workers and supplies that affect provider stress and PCMC. These are important but beyond the scope of one intervention. This intervention is intended to help providers cope and provide better care amid the structural challenges. However, by collecting data on these issues and engaging leadership, we will provide the data and platform to prioritize and address structural challenges and inform policy decisions at the county, regional, and national levels. Additionally, the problem-solving strategies identified during the intervention period may help address and advocate for some of these structural challenges.

While recruitment and retention of providers may be a challenge, we will use lessons from the pilot studies, where we have achieved our target sample sizes, even during the COVID-19 pandemic. We have longstanding relationships and collaborations with health systems leaders in the study counties/regions, which will be critical to our success. In addition, our prior work has indicated both high need and interest in this intervention in the study areas [20, 52]. To reduce attrition, we will work with the county leadership to minimize the transfer of providers during the study period where possible. To mitigate challenges with the recruitment of women, we will utilize lessons from our prior studies such as working with community health volunteers and providing small incentives to both the women and volunteers who facilitate their recruitment. Other potential challenges include contamination from other related interventions in the study areas. As part of our process monitoring, we will document ongoing activities at each site to help explain unexpected findings.

Integrated provider-targeted interventions that give providers the opportunity to learn, practice, and reflect on their own as well as the patient experience with attention to the needs of the most vulnerable, and which create an enabling environment for behavior change, have the potential to improve both the providers and women鈥檚 maternal experiences. Incorporating such interventions into in-service professional development programs will help advance global efforts to promote PCMC. If the intervention is proven to be effective, it will be disseminated to the Kenyan and Ghana Ministries of Health, as well as non-government stakeholders. We anticipate expanding this work elsewhere in SSA and working to develop guidelines for scaling similar interventions. This research will address a major gap in efforts to improve MCH outcomes and achieve equitable maternal and neonatal health. The results of the trial will be disseminated through presentations, peer-reviewed publications, policy briefs, and other dissemination formats.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Alkema L, Chou D, Hogan D, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-agency Group. Lancet. 2016;387(10017):462鈥�74. .

    听 听 听

  2. WHO. PMNCH Fact Sheet. Maternal mortality. Published 2011. Accessed July 17, 2013.

  3. WHO. Making pregnancy safer: the critical role of the skilled attendant. Jt Statement WHO ICM FIGO Geneva. Published online 2004.

  4. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323鈥�33. .

    听 听 听

  5. UNICEF, Delivery. care: Joint UNICEF/WHO database 2021 of skilled health personnel, based on population based national household survey data and routine health systems. UNICEF DATA. Published 2021. Accessed November 1, 2021.

  6. UNICEF. Delivery care. UNICEF global databases. 2023, based on MICS, DHS and other nationally representative household surveys. UNICEF global databases, 2023, based on MICS, DHS and other nationally representative household surveys. Published 2023. Accessed April 10, 2024.

  7. Koblinsky M, Moyer CA, Calvert C et al. Quality maternity care for every woman, everywhere: a call to action. The Lancet. Published online September 2016.

  8. Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the Sustainable Development goals era: time for a revolution. Lancet Glob Health. 2018;6(11):e1196鈥�252. .

    听 听 听 听

  9. Chou VB, Walker N, Kanyangarara M. Estimating the global impact of poor quality of care on maternal and neonatal outcomes in 81 low- and middle-income countries: a modeling study. Persson L脜. ed PLOS Med. 2019;16(12):e1002990鈥�1002990. .

    听 听

  10. Tun莽alp 应, Were W, MacLennan C, et al. Quality of care for pregnant women and newborns鈥攖he WHO vision. BJOG Int J Obstet Gynaecol. 2015;122(8):1045鈥�9. .

    听 听

  11. Donabedian A. The quality of care. How can it be assessed? JAMA J Am Med Assoc. 1988;260(12):1743鈥�8.

    听 CAS听 听

  12. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. 2001. Accessed July 25, 2013.

  13. WHO. Prevention and elimination of disrespect and abuse during childbirth. WHO. Published 2014. Accessed April 5, 2017.

  14. WHO. WHO recommendations: intrapartum care for a positive childbirth experience. WHO. Published 2018. Accessed April 1. 2019.

  15. WHO. WHO recommendations on antenatal care for a positive pregnancy experience. WHO. Published 2016. Accessed October 13. 2020.

  16. White Ribbon Alliance. Respectful Maternity Care: The Universal Rights of Childbearing Women (Full charter). Published 2011. Accessed March 28. 2017.

  17. Afulani PA, Kirumbi L, Lyndon A. What makes or mars the facility-based childbirth experience: thematic analysis of women鈥檚 childbirth experiences in western Kenya. Reprod Health. 2017;14(1):180. .

    听 听 听 听

  18. Afulani PA, Phillips B, Aborigo RA, Moyer CA. Person-centred maternity care in low-income and middle-income countries: analysis of data from Kenya, Ghana, and India. Lancet Glob Health. 2019;7(1):e96鈥�109. .

    听 听 听

  19. Afulani PA, Sayi TS, Montagu D. Predictors of person-centered maternity care: the role of socioeconomic status, empowerment, and facility type. 国产情侣 Health Serv Res. 2018;18(1):360. .

    听 听 听 听

  20. Afulani PA, Aborigo RA, Walker D, Moyer CA, Cohen S, Williams J. Can an integrated obstetric emergency simulation training improve respectful maternity care? Results from a pilot study in Ghana. Birth Berkeley Calif. Published Online January. 2019;24. .

  21. Moyer CA, Mustafa A. Drivers and deterrents of facility delivery in sub-saharan Africa: a systematic review. Reprod Health. 2013;10(1):40. .

    听 听 听 听

  22. Bohren MA, Hunter EC, Munthe-Kaas HM, Souza JP, Vogel JP, G眉lmezoglu AM. Facilitators and barriers to facility-based delivery in low- and middle-income countries: a qualitative evidence synthesis. Reprod Health. 2014;11(1):71. .

    听 听 听 听

  23. Andersen HM. Villagers: Differential treatment in a Ghanaian hospital. Soc Sci Med. 2004;59:2003鈥�12.

    听 听 听

  24. Atinga RA, Bawole JN, Nang-Beifubah A. Some patients are more equal than others鈥�: patient-centred care differential in two-tier inpatient ward hospitals in Ghana. Patient Educ Couns. 2016;99(3):370鈥�7. .

    听 听 听

  25. Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013;3(1). .

  26. Oliveira VC, Refshauge KM, Ferreira ML, et al. Communication that values patient autonomy is associated with satisfaction with care: a systematic review. J Physiother. 2012;58(4):215鈥�29. .

    听 听 听

  27. Hodnett ED, Gates S, Hofmeyr GJ, Sakala C. Continuous support for women during childbirth. The Cochrane Collaboration, Hodnett ED, eds. Cochrane Database Syst Rev. Published online July 15, 2013. Accessed August 7, 2013.

  28. Bohren MA, Hofmeyr GJ, Sakala C, Fukuzawa RK, Cuthbert A. Continuous support for women during childbirth. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2017. .

  29. Sudhinaraset M, Landrian A, Afulani PA, Diamond-Smith N, Golub G. Association between person-centered maternity care and newborn complications in Kenya. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. Published online September 23, 2019.

  30. Sudhinaraset DM, Landrian MA, Golub MGM, Cotter MSY, Afulani DPA. Person-centered maternity care and postnatal health: associations with maternal and newborn health outcomes. AJOG Glob Rep Published Online January. 2021;27:100005. .

    听 听

  31. Minckas N, Gram L, Smith C, Mannell J. Disrespect and abuse as a predictor of postnatal care utilisation and maternal-newborn well-being: a mixed-methods systematic review. BMJ Glob Health. 2021;6(4):e004698. .

    听 听 听 听

  32. Attanasio LB, Ranchoff BL, Paterno MT, Kjerulff KH. Person-Centered Maternity Care and Health Outcomes at 1 and 6 months Postpartum. J Womens Health Published Online September. 2022;2. .

  33. Miller S, Abalos E, Chamillard M, et al. Beyond too little, too late and too much, too soon: a pathway towards evidence-based, respectful maternity care worldwide. Lancet Published Online September. 2016. .

    听 听

  34. Bohren MA, Vogel JP, Tun莽alp 脰, et al. By slapping their laps, the patient will know that you truly care for her: a qualitative study on social norms and acceptability of the mistreatment of women during childbirth in Abuja, Nigeria. SSM - Popul Health. 2016;2:640鈥�55. .

    听 听 听 听

  35. Jewkes R, Abrahams N, Mvo Z. Why do nurses abuse patients? Reflections from South African obstetric services. Soc Sci Med. 1998;47:1781鈥�95.

    听 听 CAS听 听

  36. Sen G, Reddy B, Iyer A. Beyond measurement: the drivers of disrespect and abuse in obstetric care. Reprod Health Matters. 2018;26(53):6鈥�18. .

    听 听 听

  37. Warren CE, Njue R, Ndwiga C, Abuya T. Manifestations and drivers of mistreatment of women during childbirth in Kenya: implications for measurement and developing interventions. 国产情侣 Pregnancy Childbirth. 2017;17:102. .

    听 听 听 听

  38. Afulani PA, Buback L, Kelly AM, Kirumbi L, Cohen CR, Lyndon A. Providers鈥� perceptions of communication and women鈥檚 autonomy during childbirth: a mixed methods study in Kenya. Reprod Health. 2020;17(1):85. .

    听 听 听 听

  39. Buback L, Kinyua J, Akinyi B, Walker D, Afulani PA. Provider perceptions of lack of supportive care during childbirth: a mixed methods study in Kenya. Health Care Women Int. 2021;0(0):1鈥�22. .

    听 听

  40. Jewkes R, Penn-Kekana L. Mistreatment of women in Childbirth: Time for Action on this important dimension of violence against women. PLOS Med. 2015;12(6):e1001849. .

    听 听 听 听

  41. Freedman LP, Kruk ME. Disrespect and abuse of women in childbirth: challenging the global quality and accountability agendas. Lancet. 2014;384(9948):e42鈥�4. .

    听 听 听

  42. Downe S, Lawrie TA, Finlayson K, Oladapo OT. Effectiveness of respectful care policies for women using routine intrapartum services: a systematic review. Reprod Health. 2018;15(1):23. .

    听 听 听 听

  43. Diamond-Smith N, Lin S, Peca E, Walker D. A landscaping review of interventions to promote respectful maternal care in Africa: opportunities to advance innovation and accountability. Midwifery. 2022;115:103488. .

    听 听 听

  44. Afulani PA, Kelly AM, Buback L, Asunka J, Kirumbi L, Lyndon A. Providers鈥� perceptions of disrespect and abuse during childbirth: a mixed-methods study in Kenya. Health Policy Plan. 2020;35:577鈥�86.

  45. Afulani PA, Aborigo RA, Nutor JJ, et al. Self-reported provision of person-centered Maternity Care among providers in Kenya and Ghana: Scale Validation and Examination of Associated factors. Social Science Research Network; 2021. .

  46. Afulani PA, Ongeri L, Kinyua J, Temmerman M, Mendes WB, Weiss SJ. Psychological and physiological stress and burnout among maternity providers in a rural county in Kenya: individual and situational predictors. 国产情侣 Public Health. 2021;21(1):453. .

    听 听 听 听

  47. Afulani PA, Oboke EN, Ogolla BA, et al. Caring for providers to improve patient experience (CPIPE): intervention development process. Glob Health Action. 2023;16(1):2147289. .

    听 听 听

  48. McLeroy KR, Bibeau D, Steckler A, Glanz K. An Ecological Perspective on Health Promotion Programs. Health Educ Behav. 1988;15(4):351鈥�77. .

    听 CAS听 听

  49. Glanz K, Rimer KB. Theory at a Glance: A Guide for Health Promotion Practice. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. NIH Pub. No. 97-3896. Washington, DC: NIH.; 1997.

  50. San Francisco Department of Public Health. Trauma Informed Systems Initiative 2014 Year in Review. Published online 2015.

  51. Walker DM, Holme F, Zelek ST, et al. A process evaluation of PRONTO simulation training for obstetric and neonatal emergency response teams in Guatemala. 国产情侣 Med Educ. 2015;15(1):117. .

    听 听 听 听

  52. Afulani PA, Dyer J, Calkins K, Aborigo RA, Mcnally B, Cohen SR. Provider knowledge and perceptions following an integrated simulation training on emergency obstetric and neonatal care and respectful maternity care: a mixed-methods study in Ghana. Midwifery. 2020;85:102667. .

    听 听 听

  53. Health Policy Project. Kenya County Health Fact Sheets. Published online 2015.

  54. Ghana Health Service. Regional health Directorate-Upper East Region. 2018 Annual Report.

  55. Ghana Health Service. Upper East Regional Profile-2021.

  56. North East Regional Health Directorate. Midyear Performance Review Report 2021.

  57. Rossi PH, Lipsey MW, Freeman HE. Evaluation: a systematic Approach. 7th ed. Thousand Oaks, CA: Sage Publications, Inc.; 2004. pp. 68鈥�81.

    听

  58. Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual framework for implementation fidelity. Implement Sci. 2007;2:40. .

    听 听 听 听

  59. Breitenstein SM, Gross D, Garvey C, Hill C, Fogg L, Resnick B. Implementation Fidelity in Community-based interventions. Res Nurs Health. 2010;33(2):164鈥�73. .

    听 听 听 听

  60. Afulani PA, Diamond-Smith N, Golub G, Sudhinaraset M. Development of a tool to measure person-centered maternity care in developing settings: validation in a rural and urban Kenyan population. Reprod Health. 2017;14:118. .

    听 听 听 听

  61. Afulani PA, Buback L, Essandoh F, Kinyua J, Kirumbi L, Cohen CR. Quality of antenatal care and associated factors in a rural county in Kenya: an assessment of service provision and experience dimensions. 国产情侣 Health Serv Res. 2019;19(1):1鈥�16. .

    听 听

  62. Afulani PA, Altman MR, Castillo E, et al. Development of the person-centered prenatal care scale for people of color. Am J Obstet Gynecol. 2021;225(4):427e. 1-427.e13.

    听 听

  63. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385鈥�96.

    听 听 CAS听 听

  64. Gerber M, Colledge F, M眉cke M, Schilling R, Brand S, Ludyga S. Psychometric properties of the Shirom-Melamed Burnout measure (SMBM) among adolescents: results from three cross-sectional studies. 国产情侣 Psychiatry. 2018;18. .

  65. Afulani PA, Gyamerah AO, Nutor JJ, et al. Inadequate preparedness for response to COVID-19 is associated with stress and burnout among healthcare workers in Ghana. PLoS ONE. 2021;16(4):e0250294. .

    听 听 听 CAS听 听

  66. Bower KM, Kramer MB, Warren N, et al. Development of an instrument to measure awareness and mitigation of Bias in maternal Health Care. Am J Obstet Gynecol MFM. 2023;0(0). .

  67. Afulani PA, Ogolla BA, Oboke EN, Ongeri L, Weiss SJ, Lyndon A, et al. Understanding disparities in person-centred maternity care: the potential role of provider implicit and explicit bias. Health Policy Plan. 2021;36:298鈥�311.

  68. Eberhard-Gran M, Eskild A, Tambs K, Opjordsmoen S, Samuelsen SO. Review of Validation Studies of the Edinburgh Postnatal Depression Scale. Centre for Reviews and Dissemination (UK); 2001. Accessed January 4, 2022.

  69. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377鈥�81. .

    听 听

  70. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208. .

    听 听

  71. Luellen JK, Shadish WR, Clark MH. Propensity scores: an introduction and experimental test. Eval Rev. 2005;29(6):530鈥�58. .

    听 听 听

  72. van der Laan MJ. Rose S. Targeted learning: causal inference for observational and experimental data. Springer; 2011.

  73. Enders CK. Applied Missing Data Analysis. Guilford Press; 2010. p. xv.

  74. Little RJA, Rubin DB. Statistical analysis with Missing Data. Wiley; 2019.

  75. Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330鈥�51.

    听 听 CAS听 听

  76. NCSS PASS 2021 [computer program]. Version 21. Kaysville, Utah: NCSS Statistical Software. 2021. Accessed December 17, 2021.

  77. Afulani PA, Aborigo RA, Nutor JJ, et al. Self-reported provision of person-centred maternity care among providers in Kenya and Ghana: scale validation and examination of associated factors. BMJ Glob Health. 2021;6(12):e007415. .

    听 听 听 听

  78. Crosby RA, Rothenberg R. In STI interventions, size matters. Sex Transm Infect. 2004;80(2):82鈥�5. .

    听 听 听 CAS听 听

  79. Baron RM, Kenny DA. The moderator鈥搈ediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173鈥�82. .

    听 听 CAS听 听

  80. Sandelowski M. Sample size in qualitative research. Res Nurs Health. 1995;18(2):179鈥�83. .

    听 听 CAS听 听

  81. Boddy CR. Sample size for qualitative research. Qual Mark Res Int J. 2016;19(4):426鈥�32. .

    听 听

  82. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77鈥�101. .

    听 听

  83. Proctor EK, Powell BJ, Baumann AA, Hamilton AM, Santens RL. Writing implementation research grant proposals: ten key ingredients. Implement Sci. 2012;7:96. .

    听 听 听 听

  84. Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65鈥�76. .

    听 听 听

Acknowledgements

We would like to acknowledge the respective countries, counties, and districts where the study is being conducted. We would also like to thank the providers and women participating in this research study, as well as the facility, district, sub-county, and county/regional level leadership for their support of the project.听We would also like to acknowledge Kimberley Calkins from PRONTO International for her support in the curriculum adaptation and development.

Funding

This study is funded by a Eunice Kennedy Shriver National Institute of Child Health and Human Development R01 grant to PA [R01 HD110370-02]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA

    Patience A. Afulani听&听Dilys Walker

  2. Institute for Global Health Sciences, University of California, San Francisco, CA, USA

    Patience A. Afulani,听Monica Getahun听&听Osamuedeme Odiase

  3. Kenya Medical Research Institute, Nairobi, Kenya

    Linnet Ongeri听&听Joyceline Kinyua

  4. Navrongo Health Research Centre, Navrongo, Ghana

    Raymond Aborigo听&听Ali Moro

  5. Global Programs for Research and Training, Nairobi, Kenya

    Beryl A. Ogolla

  6. Global Programs for Research and Training, Kampala, Uganda

    Jaffer Okiring

  7. Migori County Government, Migori, Kenya

    Iscar Oluoch

  8. Institute of Health Research, University of Health, and Allied Sciences (UHAS), Ho, Ghana

    Maxwell Dalaba

  9. Department of Family Health Care Nursing, School of Nursing, University of California San Francisco, San Francisco, CA, USA

    Jerry John Ouner

  10. Department of Psychology, Yale University, New Haven, USA

    Wendy Berry Mendes

  11. Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA

    Patience A. Afulani听&听Dilys Walker

  12. Department of Medicine, University of California San Francisco, San Francisco, CA, USA

    Torsten B. Neilands

Authors
  1. Patience A. Afulani

    You can also search for this author in 听

  2. Monica Getahun

    You can also search for this author in 听

  3. Linnet Ongeri

    You can also search for this author in 听

  4. Raymond Aborigo

    You can also search for this author in 听

  5. Joyceline Kinyua

    You can also search for this author in 听

  6. Beryl A. Ogolla

    You can also search for this author in 听

  7. Jaffer Okiring

    You can also search for this author in 听

  8. Ali Moro

    You can also search for this author in 听

  9. Iscar Oluoch

    You can also search for this author in 听

  10. Maxwell Dalaba

    You can also search for this author in 听

  11. Osamuedeme Odiase

    You can also search for this author in 听

  12. Jerry John Ouner

    You can also search for this author in 听

  13. Wendy Berry Mendes

    You can also search for this author in 听

  14. Dilys Walker

    You can also search for this author in 听

  15. Torsten B. Neilands

    You can also search for this author in 听

Contributions

PA: project lead, conceptualized study, study design, literature review, protocol drafting, and writing. JK, IO, WM, TN, MD, JN, RA, DW, and LO: project co-investigators, contributing to study design, protocol writing and editing. MG, BO, JO, AM, and OO: protocol implementation, reviewed and edited protocol. All authors contributed to the critical revision of the article and approved of the final manuscript for publication.

Corresponding author

Correspondence to Patience A. Afulani.

Ethics declarations

Ethics approval and consent to participate

The study protocol has been approved by the University of California, San Francisco (UCSF) Institutional Review Board (IRB no; 23-38843); the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU) (SERU/4820) and the Kenya National Commission for Science, Technology & Innovation (NACOSTI/P/23/31494) in Kenya; and the Navrongo Health Research Centre (NHRC) (NHRCCIRB555), the Ghana Health Service (011/10/23), and the Christian Health Association of Ghana (CHAG-IRB5062023) IRBs in Ghana. Further approval has been granted by the Government of Kenya at the devolved units of Migori and Homa Bay Counties, the Department of Health Services, as well as the Central Government, represented by the office of the respective County Commissioners, and by the regional and district health directorates in Ghana. All participants will provide signed informed consent prior to enrollment in the trial.

Consent for publication

This manuscript does not contain any individual person鈥檚 data in any form.

Competing interests

The authors declare no competing interests.

Additional information

Publisher鈥檚 note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article鈥檚 Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article鈥檚 Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit .

About this article

Cite this article

Afulani, P.A., Getahun, M., Ongeri, L. et al. A cluster randomized controlled trial to assess the impact of the 鈥楥aring for Providers to Improve Patient Experience鈥� (CPIPE) intervention in Kenya and Ghana: study protocol. 国产情侣 Public Health 24, 2509 (2024). https://doi.org/10.1186/s12889-024-20023-9

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-20023-9

国产情侣 Public Health

ISSN: 1471-2458

Contact us